NQ Mobile (NYSE: NQ) shares reached a new 52-week low of $4.45 after the company announced certain changes to its Board of Directors and provided a status update on its 2013 annual audit.
Regado Biosciences (NASDAQ: RGDO) shares touched a new 52-week low of $2.90 following the announcement of halt of patient enrollment in
REGULATE-PCI trial. Wedbush downgraded Regado Biosciences from Outperform to Underperform.
MELA Sciences (NASDAQ: MELA) shares reached a new 52-week low of $0.303 after the company approved a one-for-ten reverse stock split of the common stock.
Globeimmune (NASDAQ: GBIM) shares tumbled 4.71% to touch a new 52-week low of $10.53. Globeimmune has a 52-week high of $12.14.
Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Most Popular Apple Price Target Raised 15% By Evercore, Sees Revenue Growth Resuming Rumored Big Engine Order From American Could Boost GE Aviation's Bottom Line Aegis Capital Believes Valeant Pharmaceuticals' Bid For Allergan Is Looking More Promising Traders Speculating Chevron May Acquire Devon Energy (CVX, DVN) Now Is The Right Time To Buy Rite Aid Nintendo Promoted 'Mario Kart 8,' Nintendo 2DS With $9.7 Million TV Ad Campaign Related Articles (MELA + GBIM) Stocks Hitting 52-Week Lows MELA Sciences Announces Pending One-for-Ten Reverse Stock Split Hunting The Next GoPro: Short Week Brings Up To 7 IPOs IPO Lookout: IPOs Up Double Digits On The Week Stocks To Watch For June 12, 2014 Stocks To Watch For May 28, 2014 Around the Web, We're Loving... Abercrombie Stems Bleeding Sales in Key Brand A
No comments:
Post a Comment